Online Canadian Pharmacy - Best online drugs choice
Ann Pharmacy All products
Ann Pharmacy bestsellers
Ann Pharmacy FAQ
Ann Pharmacy contacts
Your cart: $0.00 (0 items)
Proceed to Checkout
We accept
VISA MasterCard AMEX Diners JCB eCHECK
Search drugs by name:
PRODUCT LIST
Pharmacy Home > ANTI-SPAM POLICY
Top products
Antispam policy
AnnPharmacy supports ONLY permission-based email management practices. In this regard, AnnPharmacy has implemented various policies and procedures that:
  • Help prevent AnnPharmacy from being used for the purpose of unsolicited email campaigns.
  • Encourage permission-based marketing.
  • Respond to all complaints suggesting AnnPharmacy has been used as a vehicle to send unsolicited email.

Spam is Unsolicited Email

Spam is unsolicited commercial email, junk mail or bulk mail that has not been requested by the recipient. In addition to being perceived as intrusive, irrelevant and often offensive, it is also typical that spam emails do not contain an option to unsubscribe from the mailing list. Simply put, spam is the opposite of permission-based emails - those that are requested, anticipated, personal and relevant.

Preventing Unsolicited Emails Via AnnPharmacy

Users must abide by a strictly enforced Terms of Service. In the "Terms of Service of AnnPharmacy, it clearly states our policy with respect to spam: "You may not use the AnnPharmacy or the products or services provided through or in connection with the AnnPharmacy to: a. send unsolicited bulk email, for commercial or non-commercial purposes. Unsolicited bulk email is defined as email sent to more than 10 individuals without their permission."

Also, users must accept that an unsubscribe option will be automatically appended to every email sent via AnnPharmacy. This is not an option. In the event that a user violates any one of our usage rules, or for any other reason deemed appropriate by AnnPharmacy, AnnPharmacy reserves the right to suspend or terminate, without notice, access to the user's account and all related data.

Encouraging Permission-Based Marketing

AnnPharmacy encourages its users to create and manage "opt-in" subscriber lists. By building and using an "opt-in" subscriber list, users can be certain that they are sending emails to recipients that have expressly given their permission to do so.

It is also important to note that subscribers receiving email campaigns by users will only see their names in the header - all other email addresses are not viewable which makes them safer from unsolicited email abuse via other recipients of the same email campaign.

Responding to Unsolicited Email Complaints

If a complaint is received regarding unsolicited emails being sent from our AnnPharmacy site or by any of our users (affiliates), an immediate investigation is undertaken.

Initial Warning - The user (affiliate) is first notified that an unsolicited email complaint has been lodged against them and: (a) Reminded of the terms they accepted in the Terms of Service. (b) Reminded that the complainant's email address will automatically be flagged for suppression if the complainant did unsubscribe. (c) Requested to manually remove the complainant's email address from their subscriber list if the address was not automatically suppressed because the complainant did not unsubscribe.

Follow-up Warning - If the complainant persists, or if there are multiple complaints, a second warning is issued. The user (affiliate) is again reminded of the Terms of Service. Additionally, the user (affiliate) is advised that if they are unable to abide by these terms, they should discontinue using the AnnPharmacy site.

  • Final Notice - If notifications of unsolicited emails continue and remain unaddressed after the follow-up warning, the user's account privileges will be suspended and eventually terminated.

Think You've Been Spammed?

Immediately unsubscribe using the "unsubscribe" option of your choice in the email. Send us a message to notify us of any unsolicited messages and provide any other information that you believe may help us in our investigation.

AnnPharmacy takes permission marketing very seriously. Thank you for reviewing our Anti-Spam Policy.

© 2002-2009 annpharmacy.com, Inc. All Rights Reserved.

Last Updated: April 20, 2008

Erection packs

Pharmacy News


The FDA has approved two additional uses for rituximab (Rituxan, Genen-tech/Biogen Idec) for patients with CD20-positive, B-cell non-Hodgkin’s lym-phoma (NHL): as a first-line treatment of previously untreated patients with fol-licular NHL in combination with cyclo-phosphamide, vincristine, and predni-solone (CVP) chemotherapy, and as a treatment for low-grade NHL in patients with stable disease or who have [...]

Coagulation factor VIIa (recombinant) (NovoSeven, Novo Nordisk) is the first recombinant therapy to be approved for the treatment of bleeding episodes and for the prevention of bleeding in patients with acquired hemophilia who are undergoing invasive surgical procedures. First introduced in 1999, NovoSeven is currently indicated for the treatment of bleeding episodes in hemophilia A or [...]

Posaconazole oral suspension (Noxafil, Schering-Plough) is now approved for patients with oropharyngeal candi-diasis, including infections refractory to itraconazole and/or fluconazole. cheap celebrex

Sitagliptin generic phosphate (Januvia, Merck), the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors, enhances the body’s own ability to lower elevated blood glucose levels. The FDA approved the tablets for use in addition to diet and exercise to improve blood sugar levels in patients with type-2 diabetes; the drug [...]

© Copyright AnnPharmacy, 2002-2009.